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Abstract
Background: Genome wide association studies reported two single nucleotide polymorphisms in ANK3 (rs9804190
and rs10994336) as independent genetic risk factors for bipolar disorder. Another SNP in ANK3 (rs10761482) was
associated with schizophrenia in a large European sample. Within the debate on common susceptibility genes for
schizophrenia and bipolar disorder, we tried to investigate common findings by analyzing association of ANK3 with
schizophrenia, bipolar disorder and unipolar depression.
Methods: We genotyped three single nucleotide polymorphisms (SNPs) in ANK3 (rs9804190, rs10994336, and
rs10761482) in a case-control sample of German descent including 920 patients with schizophrenia, 400 with
bipolar affective disorder, 220 patients with unipolar depression according to ICD 10 and 480 healthy controls.
Sample was further differentiated according to Leonhard’s classification featuring disease entities with specific
combination of bipolar and psychotic syndromes.
Results: We found no association of rs9804190 and rs10994336 with bipolar disorder, unipolar depression or
schizophrenia. In contrast to previous findings rs10761482 was associated with bipolar disorder (p = 0.015) but not
with schizophrenia or unipolar depression. We observed no association with disease entities according to
Leonhard’s classification.
Conclusion: Our results support a specific genetic contribution of ANK3 to bipolar disorder though we failed to
replicate findings for schizophrenia. We cannot confirm ANK3 as a common risk factor for different diseases.
Background
Schizophrenia and bipolar disorder are genetically com-
plex diseases with numerous proposed genetic risk fac-
tors encompassing different pathophysiological pathways
of neurotransmission, brain development or synaptic
plasticity with each small contribution to disease risk
and inconsistent results among replication studies (Stö-
ber et. al 2009) [1,2]. Recently genome wide association
studies (GWAs) lead to identification of new susceptibil-
ity genes with genome-wide levels of significance: zinc
finger gene ZNF804A on chromosome 2q32 or the
MHC-locus at 6p21 on schizophrenia. For bipolar disor-
der the most promising results have been reported for
CACNA1C and ANK3 (ankyrin 3, node of Ranvier)
[3-5]. Subsequently CACNA1C and ZNF804A were pro-
posed as common risk variants for both bipolar disorder
and schizophrenia and a Meta-analysis additionally
added the MHC-locus as a common risk factor for both
diseases [5].
ANK3 at 10q21.2 consists of 44 exons spanning ~700
kb on genomic DNA with multiple splicing variants. A
G W As t u d yb a s e do np o o l e dD N Af o u n da s s o c i a t i o n
with bipolar disorder and rs9804190 located intronic
between exon 36 and 37 at the locus ANK3 [6]. A Meta-
analysis of GWA on bipolar patients with European
ancestry reported an additional marker rs10994336,
about 340 kb distal to rs9804190, at the 3-UTR of ANK3
[7]. Further analysis suggested that each variant might
contribute independently to bipolar disorder [8].
A further SNP located 3-UTR showed suggestive
evidence of genome-wide association in a Han Chinese
sample [9]. Subsequent studies found a genetic marker at
ANK3 to be associated with schizophrenia as well. Analy-
sis in a GWA study of a Norwegian discovery sample
with a large European replication sample reported asso-
ciation of rs10761482 located near 3-UTR between exon
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Ankyrin 3 is a brain expressed member of a protein-
family linking the integral membrane proteins to the
underlying spectrin-actin cytoskeleton. The gene pro-
duct Ankyrin-G of 4377 amino acids locates on axonal
initial segment and at nodes of Ranvier in the central
and peripheral neurons. Ankyrin-G is proposed to play
a regulatory role on sodium channel function, cell adhe-
sion and neuronal development [11-16]. A post mortem
study reported reduced immunoreactive of Ankyrin-G
in pyramidal neurons in the superficial cortical layer of
the dorsolateral prefrontal cortex in subjects with schi-
zophrenia [17].
Within the debate on common susceptibility genes for
schizophrenia and bipolar disorder we attempted to
replicate common findings of a genetic association for
different disease entities by analyzing association of
ANK3 with major psychosis in a case-control study with
SNPs rs9804190, rs10994336, and rs10761482. For diag-
nosis we used beside ICD10 Leonhard’s classification
separating disease entities with specific combination of
bipolar and psychotic syndromes [18].
Karl Leonhard divides psychoses into five main
groups, systematic schizophrenias, unsystematic schizo-
phrenias and cycloid psychoses. Affective psychoses are
subdivided into bipolar manic depression and monopo-
lar depression. In family and twin studies based on
Leonhard’s classification, a different genetic background
for each diagnostic category was demonstrated [19]
Methods
Index cases were recruited from the Department of Psy-
chiatry, Psychosomatics and Psychotherapy at of the
University of Würzburg. The sample encompassed 920
cases (631 males, 68%) with psychosis according to
ICD10 for schizophrenia or related diseases with an
average age at onset of 26.5 years and an average age at
recruitment of 41 years including 182 cases with schi-
zoaffective disorder (ICD10 F20-F25). 400 cases (231
males, 58%) with bipolar disorder (F30-F31) with an
average age at onset of 32 years and an average age at
recruitment of 42.5 years and 220 cases (134 males,
61%) with unipolar depression (F32-F33). with an aver-
age age at onset of 43 years and an average age at
recruitment of 51 years.
Sample was further subdivided according to Leon-
hard’s classification systematic schizophrenias (n = 228),
unsystematic schizophrenias (n = 635), cycloid psychosis
(n = 309), manic depression (n = 284) and monopolar
depression (n = 90) [17]. Diagnosis in differentiated psy-
chopathology was made by repeated personal examina-
tions of experienced psychiatrists (BP, MG, GS).
The 480 volunteer control subjects (283 males, 59%)
were recruited from the blood donor centre at the Uni-
versity of Würzburg. The average age of recruitment
was 29 years. The preponderance of males in both sam-
ples avoided gender distortion in comparison of cases
and controls. All subjects were unrelated and of German
Caucasian descent. The Ethics Committee of the Uni-
versity of Würzburg had approved the study, and writ-
ten informed consent was obtained from all subjects.
PCR for allelic discrimination was performed in a final
reaction volume of 20 μl containing 20 ng genomic
DNA and 10 μlo f2×T a q M a n
®Universal PCR Master
Mix (Applied Biosystems) and 1 μlo f2 0×T a q M a n ™
SNP genotyping assay including fluorescent tags specific
for the wild type allele and the variant allele. Marker
amplification was performed in microtiter plates on Bio-
metra thermocyclers (Whatman). PCR amplification
conditions were according to the manufacturer’sr e c o m -
mendation [10 min at 95°C followed by 15 sec at 92°C
and 60 sec at 60°C for 40 cycles]. Allelic discrimination
with endpoint detection of fluorescence was performed
at 60°C on an ABI prism 7000 sequence detection sys-
tem followed by analysis with an appropriate software
package (Applied Biosystems). All genotype experiments
were made at least in duplicate, with quality control of
automated allele calling by two independent operators
blind to phenotype. The calling rate was 99%.
Software FAMHAP was used to test for association
[20]. Hardy-Weinberg equilibrium (HWE) and pairwise
standardized linkage disequilibrium (LD) were calculated
with the program HAPLOVIEW [21]. The software
“stastical power calculator” was used analyzing power
for association test [22].
Results
Corresponding to HAPMAP data rs9804190 locates
between LD-block 7 and 8, rs10761482 in LD-block 26
and rs10994336 in a downstream LD block of ANK3.
Thus, linkage disequilibrium (LD) was low between the
analyzed markers with LD’ 0.018 between rs9804190
and rs10761482, 0.0060 between rs9804190 and
rs10994336 and 0.72 between rs10761482 and
rs10994336 located at 3’-UTR. All SNPs were in HWE.
Analyzing Allele and genotype frequencies in cases
according to the ICD 10 classification with schizophre-
nia, bipolar disorder or major depression revealed no
association for SNPs rs9804190 and rs10994336, (table 1
and 2). We observed no significant difference between
cases and controls for subgroup with schizoaffective dis-
order. SNP rs10761482 was associated with bipolar dis-
order (p = 0.015, OR 1.304, CI 1.065 - 1.595) but not
with schizophrenia, nor with subgroup schizoaffective
disorder nor with unipolar depression (table 1 and 2).
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hard’s classification. Analyzing association of SNPs with
schizophrenic spectrum divided into subgroups systema-
tic schizophrenias, unsystematic schizophrenias and
cycloid psychosis provided no significance. Likewise
affective diseases with manic depression and monopolar
depression reached no significant association.
Analyzing haplotype with FAMHAP provided no
further risks haplotype concordant with observed low
LD.
Our study population with 1540 cases and 480 con-
trols had a power of 55.1% to replicate the reported
association with bipolar disorder and of 69.1% with schi-
zophrenia (alpha = 0.05%).
Discussion
Common susceptibility genes for schizophrenia and
bipolar disorder challenge traditional diagnostic cate-
gories and boundaries between schizophrenia and bipo-
lar disorder. We attempt to replicate genetic association
findings of ANK3 as a possible common risk factor for
schizophrenia and affective disorders in a case control
study of > 2000 subjects of German descent. Analysis of
previous associated SNPs in different LD-Blocks, located
intronic (rs9804190 and rs10761482) or 30 kb down-
stream of ANK3 (rs10994336) found a nominally signifi-
cant association of SNP rs10761482 with bipolar
disorder (p = 0.015, OR 1.304) but not with schizophre-
nia (table 1 and 2). Thus, association of this marker
with schizophrenia in a GWA analysis of European sam-
ples could not be confirmed [16].
We failed to confirm an association of rs9804190 and
rs10994336 with bipolar disorder reported in two pre-
vious GWA studies. We found no association with uni-
polar depression or schizophrenia including subgroup of
schizoaffective disorder (table 1 and 2) [13,14]. Analyzing
haplotype provided no further risks haplotype concor-
dant with observed low LD between the markers.
Our failure to replicate previous findings could be due
to insufficient sample size. The study had a power of
55.1% to replicate reported association with bipolar dis-
order and of 69.1% with schizophrenia (alpha = 0.05%)
[14,16]. However, in our study were cases and controls
of the same genetic background, minimizing a distortion
regarding genetic heterogeneity. The strength of our
strategy is the combination of operational diagnostic cri-
teria (ICD-10) and Leonhard’s categorical diagnostic
approach. In search for common risk factors for schizo-
phrenia and bipolar disorder we found no association in
the schizophrenic spectrum neither with systematic
schizophrenias nor with subgroups with a specific com-
bination of bipolar and psychotic syndromes: Particu-
larly the unsystematic schizophrenias and strictly
defined manic depression with strong genetic back-
ground [19,23,24]. Other disease entities according to
Leonhard’s classification were not associated to any of
the markers.
Our data support findings from two meta-analyses of
GWA-studies searching for common risk variants in
ANK3 for schizophrenia, bipolar disorder or unipolar
depression: One study combining Meta-analysis and
additional genotyping of a bipolar and unipolar sample
from the US, the UK, Ireland, and Netherlands, found
no association of variants in ANK3 and unipolar depres-
sion. Another Meta-analysis on GWA studies based on
schizophrenia and bipolar disorder cohorts with samples
from UK observed no significant results for schizophre-
nia. Both Meta-analyses suggested a specific effect of
ANK3 for bipolar disorder [25,5].
Since genetically associated SNPs around ANK3 are
intronic or in downstream regions located, causative
coding variants or associated haplotype blocks are still
Table 1 Bipolar disorder according to ICD10: Genotype distribution and test for association
Cases Controls Cases Controls Cases Controls Cases Controls
SNP n n CC CC P CT CT P TT TT P
rs9804190 (C/T) 400 480 0.618 0.578 0.237 0.327 0.380 0.101 0.056 0.042 0.337
rs10994336 (C/T) 400 480 0.843 0.874 0.182 0.154 0.119 0.13 0.003 0.006 0.415
rs10761482 (C/T) 400 480 0.652 0.572 0.015 0.300 0.359 0.063 0.048 0.069 0.19
P: test for association (FAMHAP); CC, CT, TT: genotypes
Table 2 Schizophrenia according to ICD10: Genotype distribution and test for association
Cases Controls Cases Controls Cases Controls Cases Controls
SNP n n CC CC P CT CT P TT TT P
rs9804190 (C/T) 920 480 0.577 0.578 0.949 0.369 0.380 0.674 0.055 0.042 0.284
rs10994336 (C/T) 920 480 0.884 0.874 0.617 0.112 0.119 0.689 0.004 0.006 0.62
rs10761482 (C/T) 920 480 0.557 0.572 0.593 0.394 0.359 0.196 0.048 0.069 0.113
P: test for association (FAMHAP); CC, CT, TT: genotypes
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siological causative factor a recent study reported evi-
dence for cis-acting regulation of ANK3 by testing for
allelic expression imbalance, but the study failed to attri-
bute dysregulation to risk-associated SNPs [26].
Conclusions
In conclusion, our results support a genetic contribution
of ANK3 to ICD 10 bipolar disorder, though we failed
to replicate findings for schizophrenia according to ICD
10 or Leonhard’s classification. Our study cannot con-
firm ANK3 as a common risk factor for both diseases,
challenging the hypothesis that bipolar disorder and
schizophrenia are just different phenotypes of the same
disease.
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